|
|
|
|
LEADER |
01896cam a2200577 4500 |
001 |
PPN00339249X |
005 |
20230207060900.0 |
010 |
|
|
|a 2-86911-246-7
|b br.
|
020 |
|
|
|a FR
|b 09511230
|
021 |
|
|
|a FR
|b DL 94-36054
|
035 |
|
|
|a sib0592565
|
035 |
|
|
|a ocm31998539
|
035 |
|
|
|a urouen76255
|
035 |
|
|
|a DYNIX_BUNAN_187546
|
035 |
|
|
|a frBN018104565
|
035 |
|
|
|a (OCoLC)31998539
|
073 |
|
0 |
|a 9782869112469
|
100 |
|
|
|a 19941117h19951995k y0frey0103 ba
|
101 |
0 |
|
|a fre
|
102 |
|
|
|a FR
|
105 |
|
|
|a y z 000yy
|
106 |
|
|
|a r
|
200 |
1 |
|
|a Le marketing pharmaceutique
|b Texte imprimé
|f Dr Charles Harboun
|
210 |
|
|
|a Paris
|c Eska
|d 1995
|
215 |
|
|
|a 1 vol. (268 p.)
|c couv. ill. en coul.
|d 24 cm
|
225 |
0 |
|
|a Marketing
|
305 |
|
|
|a Autre(s) tirage(s) : 2004
|
320 |
|
|
|a Bibliogr. p. 267-268
|
410 |
|
| |
|0 003227170
|t Marketing (Paris)
|x 1258-0287
|
606 |
|
|
|3 PPN027476014
|a Marketing
|2 rameau
|
606 |
|
|
|3 PPN040697010
|a Préparations pharmaceutiques
|2 fmesh
|
606 |
|
|
|3 PPN040696820
|a Industrie pharmaceutique
|2 fmesh
|
606 |
|
|
|3 PPN027292630
|a Industrie pharmaceutique
|3 PPN027476014
|x Marketing
|3 PPN027226794
|y France
|2 rameau
|
606 |
|
|
|3 PPN040736342
|a Marketing des services de santé
|2 fmesh
|
606 |
|
|
|3 PPN027239144
|a Médicaments
|3 PPN028242998
|x Commercialisation
|3 PPN027226794
|y France
|2 rameau
|
675 |
|
|
|a 65
|v Éd. 1967
|
676 |
|
|
|a 615
|v 21
|
676 |
|
|
|a 615.068
|
676 |
|
|
|a 650
|
680 |
|
|
|a HF 5439 .D75
|
686 |
|
|
|a QV 736
|2 usnlm
|
700 |
|
1 |
|3 PPN033642923
|a Harboun
|b Charles
|4 070
|
801 |
|
3 |
|a FR
|b Abes
|c 20091120
|g AFNOR
|
801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
801 |
|
3 |
|a FR
|b BN
|g AFNOR
|
915 |
|
|
|5 441092103:179597698
|a 0082002385
|b 0082002385
|
919 |
|
|
|5 441092103:179597698
|a 0082002385
|
930 |
|
|
|5 441092103:179597698
|b 441092103
|a 2012 / 1198
|j u
|
998 |
|
|
|a 214930
|